Hostname: page-component-6766d58669-mzsfj Total loading time: 0 Render date: 2026-05-23T09:19:39.742Z Has data issue: false hasContentIssue false

Momentary dynamics of inner speech varieties, auditory verbal hallucinations, and affect in schizophrenia spectrum disorders: an experience sampling study

Published online by Cambridge University Press:  12 January 2026

Lawrence Kin-hei Chung
Affiliation:
Department of Psychology, The Chinese University of Hong Kong, Hong Kong SAR, China
Thomas J. Whitford
Affiliation:
School of Psychology, University of New South Wales (UNSW Sydney), Sydney, Australia
Anson Kai Chun Chau
Affiliation:
Department of Psychiatry, The University of Hong Kong, Hong Kong SAR, China
Sandra Sau-man Chan
Affiliation:
Department of Psychiatry, The Chinese University of Hong Kong, Hong Kong SAR, China
George Heung-chuen Chong
Affiliation:
Clinical Psychology Service, Kwai Chung Hospital, Hong Kong SAR, China
Suzanne Ho-wai So*
Affiliation:
Department of Psychology, The Chinese University of Hong Kong, Hong Kong SAR, China
*
Corresponding author: Suzanne Ho-wai So; Email: shwso@psy.cuhk.edu.hk
Rights & Permissions [Opens in a new window]

Abstract

Background

Auditory verbal hallucinations (AVH) in schizophrenia spectrum disorders (SSDs) may arise from misattributed inner speech. However, it is unclear if inner speech frequency and phenomenology differ in schizophrenia-spectrum voice-hearers compared with healthy individuals, and how different inner speech varieties relate to AVH and affect. Using experience sampling methodology (ESM), this study examined the moment-to-moment dynamics between inner speech varieties, AVH, and affect.

Methods

Participants completed 6 days of ESM on an electronic device, responding to 10 daily prompts on inner speech varieties (i.e. dialogic, evaluative, other people, condensed, and positive), AVH, and affect. Responses from 32 individuals with SSDs with current AVH (‘SSD’) and 34 healthy controls (‘HC’) were analyzed using linear mixed modeling.

Results

SSD reported significantly more inner speech moments and higher momentary intensity of evaluative, other people, condensed, and positive inner speech compared with HC, but not for dialogic inner speech. Within SSD, higher momentary intensities of dialogic, evaluative, other people, and condensed inner speech were associated with higher AVH levels. Momentary negative affect (NA) moderated the association between evaluative inner speech and AVH, with a stronger association at higher NA levels.

Conclusions

SSDs with current AVH experience more frequent inner speech and exhibit a distinct phenomenological profile compared with healthy individuals. Several inner speech varieties are associated with AVH severity momentarily, supporting the hypothesis that inner speech contributes to AVH at the phenomenological level. This study highlights the emotional state as an important moderator of the inner speech–AVH relationship and as a potential therapeutic target.

Information

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press
Figure 0

Table 1. Demographic and clinical characteristics of individuals with schizophrenia spectrum disorders and healthy controls

Figure 1

Table 2. Descriptive statistics of ESM items assessing affect, inner speech, and AVH in individuals with schizophrenia spectrum disorders and healthy controls

Figure 2

Table 3. Momentary associations between inner speech varieties and AVH, and the moderating effect of momentary affect and baseline negative emotional states in individuals with schizophrenia spectrum disorders (n = 32)

Figure 3

Table 4. Momentary associations between inner speech varieties and affect in individuals with schizophrenia spectrum disorders (n = 32) and healthy controls (n = 34)